May 24, 2026 by Reuben Gregg Brewer3 Portfolio Moves Stock Market Investors Should Make Before the End of the YearMarkets are always changing, and so is your portfolio; keeping on top of the stocks you own is vital.
May 24, 2026 by Reuben Gregg BrewerWall Street Is Sleeping on This Dividend King Industrial Stock, and That's Your OpportunityThere's no question that this high-yield Dividend King is dealing with issues, but the biggest problems are already in the rearview mirror.
May 24, 2026 by Billy DubersteinSpaceX Is Going Public: Here's the 1 Thing the Company Must Get Right to Justify a $1.5 Trillion ValuationIs SpaceX worth $1.5 trillion? It had better do this.
May 24, 2026 by Josh Kohn-LindquistDoximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale?Doximity stock has gotten clobbered this year, down 56%. Here's the short thesis for why I think the market's reaction is overdone.
May 24, 2026 by Kailey Hagen, CFPHere's Who Will Qualify for a $1,000 Government-Backed IRA Match in 2027This could be a big help for some savers, though it won't be an option for everyone.
May 24, 2026 by James BrumleyFull Retirement Age Is 67 for Everyone Born in 1960 or Later -- What That Costs You If You Claim EarlyThe idea of filing for benefits as soon as you're eligible sounds great... until you really start looking at the numbers.
May 24, 2026 by David Jagielski, CPAWhat's the Better Dividend Stock Today: AbbVie or Pfizer?These healthcare giants have been top dividend stocks for years, and both could be intriguing options to consider right now.
May 24, 2026 by Marc Guberti1 Artificial Intelligence (AI) Stock Flying Under the Radar That I Think Every Investor Should ConsiderCipher Digital is an underrated AI stock that can outpace the S&P 500 over the long run.
May 24, 2026 by Keithen DruryIs Microsoft Stock a Steal Right Now?Microsoft stock hasn't been this cheap, measured by the price-to-cash flow ratio, since 2019.
May 24, 2026 by Justin PopeThe Best Dividend Stocks to Buy and Hold ForeverThe list of companies you can trust indefinitely is quite short. Here are three of them.
May 24, 2026 by Reuben Gregg Brewer3 Portfolio Moves Stock Market Investors Should Make Before the End of the YearMarkets are always changing, and so is your portfolio; keeping on top of the stocks you own is vital.
May 24, 2026 by David Dierking3 ETFs Built for the Slower Summer Trading SeasonWhile trading activity tends to slow down in the summer, history suggests that downside catalysts can sometimes appear during this time.
May 24, 2026 by Kailey Hagen, CFPWill the 2027 Social Security COLA Break the 45-Year High of 8.7% Set in 2023? Here's What We Know.There are still several months to go, but all signs point to an above-average COLA so far.
May 24, 2026 by Jonathan PoncianoDriven Brands Generated $1.9 Billion in Revenue. So Why Did an Investor Cut $4 Million?Driven Brands operates a multi-brand network of automotive service and repair centers serving both retail and commercial clients.
May 24, 2026 by Jonathan PoncianoFutu Stock Plunged 30% on Regulatory News. This Investor Was Already OutFutu Holdings delivers digital brokerage and wealth management solutions to retail and institutional investors across international markets.
May 24, 2026 by Matthew BenjaminAre the Bond Vigilantes Coming for the Stock Market?A spike in bond yields in reaction to rising inflation could hurt share prices.
May 24, 2026 by Jonathan PoncianoThis Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 MillionStructure Therapeutics advances oral therapies for chronic diseases, with a pipeline focused on metabolic and pulmonary conditions.
May 24, 2026 by Reuben Gregg BrewerWall Street Is Sleeping on This Dividend King Industrial Stock, and That's Your OpportunityThere's no question that this high-yield Dividend King is dealing with issues, but the biggest problems are already in the rearview mirror.
May 24, 2026 by Jonathan PoncianoThis Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last QuarterThis biotechnology firm develops clinical-stage therapies for autoimmune and neuroinflammatory diseases using proprietary TYK2 inhibitors.
May 24, 2026 by Jonathan PoncianoThis SaaS Stock Raised Its 2026 Outlook. A Fund Just Exited a $39 Million StakeThis SaaS provider delivers marketing automation and customer data solutions to ecommerce clients across North America and Europe.
May 24, 2026 by Billy DubersteinSpaceX Is Going Public: Here's the 1 Thing the Company Must Get Right to Justify a $1.5 Trillion ValuationIs SpaceX worth $1.5 trillion? It had better do this.
May 24, 2026 by Keithen DruryAmazon Is Spending $200 Billion on AI Infrastructure. Here's What It Means for Investors.Amazon is spending more than anyone else on data centers.
May 24, 2026 by Selena MaranjianWarren Buffett Successor Greg Abel Could Be Buying $14.2 Billion Worth of This Stock Right NowThere are several strong candidates for Berkshire's massive cash pile.
